{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "3128656", "DateCompleted": {"Year": "1988", "Month": "05", "Day": "24"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "12"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0386-846X", "JournalIssue": {"Volume": "10", "Issue": "11", "PubDate": {"Year": "1987", "Month": "Nov"}}, "Title": "Journal of pharmacobio-dynamics", "ISOAbbreviation": "J Pharmacobiodyn"}, "ArticleTitle": "A novel antitumor cyclic hexapeptide (RA-700) obtained from Rubiae radix.", "Pagination": {"StartPage": "616", "EndPage": "623", "MedlinePgn": "616-23"}, "Abstract": {"AbstractText": ["The antitumor activity of a newly obtained cyclic hexapeptide, RA-700, from Rubiae Radix was studied using several murine experimental tumor systems. In P388 leukemia (inoculated intraperitoneally (i.p.), administered i.p.: i.p.-i.p.) the maximal increase in life span (ILSmax) resulting from an administration of RA-700 (4 mg/kg/d for 9 d) was 134% and the therapeutic ratio was 400. These values indicate that RA-700 has higher anti-tumor activity and broader active dose range than that of mitomycin C (MMC, 1 mg/kg/d for 9 d) which was used as a positive control. In the study of the treatment schedules on P388, RA-700 had the highest activity by consecutive injections. In MOPC-104E mouse plasmacytoma system (i.p.-i.p.), ILSmax of RA-700 (2.5 mg/kg/d for 9 d) was 84%. In a solid tumor, colon adenocarcinoma 38 (subcutaneously (s.c.)-intravenously (i.v.], RA-700 (4 mg/kg/d for 11 d) showed complete cures (8/8) compared to MMC (0.5 mg/kg/d for 11 d) which showed one cure out of 8 animals. In the study of a model of the inhibition of lymph node metastasis using P388 leukemia, the administration of RA-700 at more than 2.5 mg/kg/d i.v. for 7 d resulted in the survival of all animals (5/5) for over 60 d. In the amputation system of the same metastasis model at a dose of 4 mg/kg/d i.v. for 7 d, 3 animals out of 5 survived over 60 d.(ABSTRACT TRUNCATED AT 250 WORDS)"]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ome Research Laboratories, Tobishi Pharmaceutical Co., Ltd., Tokyo, Japan."}], "LastName": "Hamanaka", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ohgoshi", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kawahara", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Yamakawa", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tsuruo", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tsukagoshi", "ForeName": "S", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "J Pharmacobiodyn", "NlmUniqueID": "7901854", "ISSNLinking": "0386-846X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Mitomycins"}, {"RegistryNumber": "0", "NameOfSubstance": "Peptides, Cyclic"}, {"RegistryNumber": "50SG953SK6", "NameOfSubstance": "Mitomycin"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}, {"RegistryNumber": "HVM25O0351", "NameOfSubstance": "RA VII"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "toxicity"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Doxorubicin"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia P388"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred ICR"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred Strains"}, {"QualifierName": [], "DescriptorName": "Mitomycin"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Mitomycins"}, {"QualifierName": [], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms, Experimental"}, {"QualifierName": ["pharmacology", "toxicity"], "DescriptorName": "Peptides, Cyclic"}, {"QualifierName": ["analysis"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1987", "Month": "11", "Day": "1"}, {"Year": "1987", "Month": "11", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1987", "Month": "11", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["3128656", "10.1248/bpb1978.10.616"]}}]}